Here are five highlights:
1. The rising incidence of hospital-acquired infection is fueling market growth.
2. Factors that may impede market expansion include the growing number of multidrug resistant bacterial strains and inadequate management of antibiotic resistance.
3. In 2013, the hospital infection therapeutics market reached $3 billion.
4. The report analysts expect the market to total $3.6 billion by 2020, increasing at a 3.1 percent compound annual growth rate from 2014 to 2020.
5. In 2013, North America led the market with a 36.3 percent market share.
More articles on quality & infection control:
Mylan has plans to set up own pharmacy to sell EpiPen — 6 things to know
Patient Safety Movement Foundation to offer 3rd fishing trip with former President Jimmy Carter: 4 things to know
10 most popular quality and infection control stories of 2016
